These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1114967)

  • 1. Development and management of extrapyramidal symptoms in hypertensive patients treated with diazoxide.
    Pohl JE
    Am Heart J; 1975 Mar; 89(3):401-2. PubMed ID: 1114967
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of extrapyramidal symptoms in hypertensive patients treated with diazoxide.
    Neary D; Thurston H; Pohl JE
    Br Med J; 1973 Sep; 3(5878):474-5. PubMed ID: 4726153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Letter: Diazoxide and extrapyramidal syndromes].
    Simon P; Rambert F
    Nouv Presse Med; 1974 Mar; 3(10):608. PubMed ID: 4822956
    [No Abstract]   [Full Text] [Related]  

  • 4. Biperiden (Akineton): effective prophylactic and therapeutic anti-parkinsonian agent.
    Kline NS; Mason BT; Winick L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):838-43. PubMed ID: 4155670
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms.
    Bezchlibnyk-Butler KZ; Remington GJ
    Can J Psychiatry; 1994 Mar; 39(2):74-84. PubMed ID: 7908605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Extra-pyramidal syndrome caused by neuroleptics].
    Lambert PA
    Encephale; 1973; 62(1):78-105. PubMed ID: 4718697
    [No Abstract]   [Full Text] [Related]  

  • 7. Treating extrapyramidal reactions: some current issues.
    Gelenberg AJ
    J Clin Psychiatry; 1987 Sep; 48 Suppl():24-7. PubMed ID: 2887554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic induced extrapyramidal symptoms.
    Donlon PT; Stenson RL
    Dis Nerv Syst; 1976 Nov; 37(11):629-35. PubMed ID: 136337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Parkinson's disease and extrapyramidal syndromes with classical drugs (what can be expected from them in the levodopa era and which should be used)].
    Sigwald J
    Therapeutique; 1972 Nov; 48(9):561-8. PubMed ID: 4650525
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of drugs in schizophrenia. Asessment of drug-induced extrapyramidal reactions and of drugs given for their control.
    Mindham RH
    Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):395-400. PubMed ID: 9965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of antiparkinson agents in preventing antipsychotic-induced extrapyramidal symptoms.
    Murphy JE; Stewart RB
    Am J Hosp Pharm; 1979 May; 36(5):641-4. PubMed ID: 36755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Syndrome involving the extrapyramidal motor systems and their drug treatment].
    Soyka D
    Fortschr Med; 1974 Aug; 92(22):906-9. PubMed ID: 4153689
    [No Abstract]   [Full Text] [Related]  

  • 13. Extrapyramidal side effects and oral haloperidol: an analysis of explanatory patient and treatment characteristics.
    Moleman P; Schmitz PJ; Ladee GA
    J Clin Psychiatry; 1982 Dec; 43(12):492-6. PubMed ID: 7161250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral diazoxide in uncontrolled malignant hypertension.
    Fang P; MacDonald I; Laver M; Hua A; Kincaid-Smith P
    Med J Aust; 1974 Oct; 2(17):621-4. PubMed ID: 4444609
    [No Abstract]   [Full Text] [Related]  

  • 15. Extrapyramidal reactions in adolescents treated with high-potency antipsychotics.
    Chiles JA
    Am J Psychiatry; 1978 Feb; 135(2):239-40. PubMed ID: 23686
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tranquilizing agents: extrapyramidal and antiparkinsonism activities].
    Bordeleau JM; Tétreault L; Elie R
    Vie Med Can Fr; 1972 Feb; 1(2):118-26. PubMed ID: 4637390
    [No Abstract]   [Full Text] [Related]  

  • 17. Temporary symptom worsening caused by manidipine hydrochloride in two patients with Parkinson's disease.
    Nakashima K; Shimoda M; Kuno N; Takahashi K
    Mov Disord; 1994 Jan; 9(1):106-7. PubMed ID: 8139589
    [No Abstract]   [Full Text] [Related]  

  • 18. Side effects of depot fluphenazines.
    Ayd FJ
    Compr Psychiatry; 1974; 15(4):277-84. PubMed ID: 4607070
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluphenazine-induced parkinsonism in the baboon: pharmacological and metabolic studies.
    Dreyfuss J; Beer B; Devine DD; Roberts BF; Schreiber EC
    Neuropharmacology; 1972 Mar; 11(2):223-30. PubMed ID: 4623662
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug induced extrapyramidal effects--a review.
    Coleman JH; Hayes PE
    Dis Nerv Syst; 1975 Oct; 36(10):591-3. PubMed ID: 1100334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.